We study the stress response to a step strain of covalently bonded gelatin gels in the temperature range where triple helix reversible crosslink formation is prohibited. We observe slow stress relaxation towards a T-dependent finite asymptotic level. We show that this is assignable to the strain-induced coil → helix transition, previously evidenced by Courty et al. [Proc. Natl. Acad. Sci. U. S. A. 102, 13457 (2005)], of a fraction of the polymer strands. Relaxation proceeds, in a first stage, according to a stretched exponential dynamics, then crosses over to a terminal simple exponential decay. The respective characteristic times τK and τf exhibit an Arrhenius-like T-dependence with an associated energy E incompatibly larger than the activation barrier height for the isomerisation process which sets the clock for an elementary coil → helix transformation event. We tentatively assign this glass-like slowing down of the dynamics to the long-range couplings due to the mechanical noise generated by the local elementary events in this random elastic medium.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1063/1.4941456 | DOI Listing |
Ann Vasc Surg
November 2024
Department of Vascular Surgery, Kawasaki Saiwai Hospital, Kawasaki, Kanagawa, Japan.
Objective: This study assessed the real-world safety and efficacy of coil embolization during endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA) for prophylactic endoleak prevention or as a reintervention for endoleak repair, using the Cerenovus family of coils (Cerenovus, Irvine, CA, USA).
Methods: This was a multicenter, retrospective cohort study of consecutive patients who underwent embolization of branching arteries during EVAR of an AAA or as a reintervention for endoleak repair, using Cerenovus coils between January 2017 and December 2021 in Japan. The primary outcome was 30-day reintervention-free survival, defined as cardiovascular mortality or any complication requiring reintervention within 30 days post procedure.
Ann Vasc Surg
January 2025
Interventional Diagnosis and Treatment Department, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.
Background: Exploring the effectiveness and safety of n-butyl-2-cyanoacrylate (NBCA) in the transarterial embolization for common endoleak during and after endovascular repair of aortic aneurysm (EVAR).
Methods: A total of 226 patients with abdominal aortic aneurysm (AAA) were treated with EVAR in 4 years from August 2019 to February 2023, including 46 patients with ruptured aneurysms (rAAA). 37 cases, 28 nonruptured AAA patients and 9 rAAA patients, developed endoleak during EVAR surgery and follow-up period and were then treated with NBCA for transarterial embolization.
Cureus
September 2024
5th Surgical Department, Hippokrateio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Background Endovascular aneurysm repair (EVAR) has evolved into treatment of choice for infrarenal abdominal aortic aneurysms (AAA). Type II endoleaks, although frequently benign, can lead to sac enlargement and rupture. Management of these endoleaks by endovascular means can be quite challenging and may require complex techniques and assistance of interventional radiologists, not always available in all vascular units.
View Article and Find Full Text PDFJ Vasc Surg Cases Innov Tech
October 2024
Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark.
Endovascular aortic aneurysm repair is widely used for the treatment of abdominal aortic aneurysm (AAA), but has a 10% to 40% incidence of type II endoleak during follow-up. There are various techniques to treat these endoleaks in the case of enlarging of the AAA, but the clinical effectiveness is low. In recent years, preemptive AAA sac embolization has shown some encouraging results with significant AAA shrinkage.
View Article and Find Full Text PDFVascular
August 2024
Section of Vascular Surgery, Veterans Affairs New Jersey Healthcare System, East Orange, NJ, USA.
Objective: To assess viability and safety of preemptive treatment of type II endoleak for abdominal aortic aneurysm (AAA) repairs.
Methods: A 69-year-old man with renal fusion (horseshoe kidney) was referred for treatment of a 5.5 cm AAA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!